• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

具有离散时间生存终点的试验中的累积分组。

Accrual by groups in trials with discrete-time survival endpoints.

机构信息

Department of Methodology and Statistics, Utrecht University, 3508 TC Utrecht, The Netherlands.

出版信息

Clin Trials. 2013 Feb;10(1):32-42. doi: 10.1177/1740774512464831. Epub 2012 Nov 30.

DOI:10.1177/1740774512464831
PMID:23203992
Abstract

BACKGROUND

In many fields of science, event status is often recorded in intervals or at discrete points in time and can be investigated in experimental settings. Conducting such trials requires thorough planning before they are actually performed.

PURPOSE

To investigate accrual by groups in a trial with discrete-time survival endpoints and to describe how to choose the number of accrual groups, the size of the accrual groups, and the duration of the trial to achieve a sufficient power level.

METHODS

In trials with multiple time periods, the event status is recorded at the end of each period, but the event may occur at any time between the time points the measurements are taken. Therefore, time is recorded discretely, but the underlying process is continuous. To find the risk of event occurrence in each time interval, a continuous-time survival function is used and the generalized linear model is applied.

RESULTS

It is observed that the combination of the number of accrual groups, the size of the accrual groups, and the duration of the trial that gives a sufficient power level depends on the shape of the continuous-time survival function, the proportion of subjects who have experienced the event after a fixed number of time periods, and the size of the treatment effect.

LIMITATIONS

The results of the study are only presented graphically, because there is no simple closed-form expression for finding the variance of the treatment effect. The authors provide MATLAB software to perform the power calculations.

CONCLUSIONS

More subjects should be recruited in each accrual group or more accrual groups should be included if the effect size or the proportion of the subjects who have experienced the event after a fixed number of time periods decreases, or the probability of the event occurrence is concentrated toward the end of the study duration.

摘要

背景

在许多科学领域,事件状态通常以时间间隔或离散时间点记录,并可在实验环境中进行研究。进行此类试验需要在实际进行之前进行彻底的规划。

目的

调查具有离散时间生存终点的试验中按组的累计情况,并描述如何选择累计组的数量、累计组的大小以及试验的持续时间,以达到足够的效力水平。

方法

在具有多个时间段的试验中,事件状态在每个时间段结束时记录,但事件可能发生在测量时间点之间的任何时间。因此,时间以离散方式记录,但基础过程是连续的。为了找到每个时间间隔内事件发生的风险,使用连续时间生存函数并应用广义线性模型。

结果

观察到,在累计组的数量、累计组的大小和试验持续时间的组合,以达到足够的效力水平,取决于连续时间生存函数的形状、在固定时间段后经历事件的受试者比例以及治疗效果的大小。

局限性

研究结果仅以图形方式呈现,因为没有简单的封闭形式表达式来找到治疗效果的方差。作者提供了 MATLAB 软件来执行效力计算。

结论

如果效果大小或在固定时间段后经历事件的受试者比例降低,或者事件发生的概率集中在研究持续时间的最后,或者事件发生的概率集中在研究持续时间的最后,则应在每个累计组中招募更多的受试者,或者应包括更多的累计组。

相似文献

1
Accrual by groups in trials with discrete-time survival endpoints.具有离散时间生存终点的试验中的累积分组。
Clin Trials. 2013 Feb;10(1):32-42. doi: 10.1177/1740774512464831. Epub 2012 Nov 30.
2
PODSE: a computer program for optimal design of trials with discrete-time survival endpoints.PODSE:用于离散时间生存终点试验最优设计的计算机程序。
Comput Methods Programs Biomed. 2013 Jul;111(1):115-27. doi: 10.1016/j.cmpb.2013.02.005. Epub 2013 Apr 8.
3
Joint monitoring and prediction of accrual and event times in clinical trials.临床试验中应计时间和事件时间的联合监测与预测。
Biom J. 2012 Nov;54(6):735-49. doi: 10.1002/bimj.201100180. Epub 2012 Aug 21.
4
Modeling and prediction of subject accrual and event times in clinical trials: a systematic review.临床试验中受试者入组和事件时间的建模与预测:系统评价。
Clin Trials. 2012 Dec;9(6):681-8. doi: 10.1177/1740774512447996. Epub 2012 Jun 6.
5
A review of statistical issues with progression-free survival as an interval-censored time-to-event endpoint.以无进展生存期作为区间删失的事件发生时间终点的统计问题综述。
J Biopharm Stat. 2013;23(5):986-1003. doi: 10.1080/10543406.2013.813524.
6
Designing clinical trials with (restricted) mean survival time endpoint: Practical considerations.设计(受限)平均生存时间终点的临床试验:实用考虑。
Clin Trials. 2020 Jun;17(3):285-294. doi: 10.1177/1740774520905563. Epub 2020 Feb 17.
7
Sample sizes for clinical trials with time-to-event endpoints and competing risks.具有事件发生时间终点和竞争风险的临床试验的样本量。
Contemp Clin Trials. 2005 Jun;26(3):386-96. doi: 10.1016/j.cct.2005.01.010. Epub 2005 Apr 26.
8
Optimal designs in longitudinal trials with varying treatment effects and discrete-time survival endpoints.具有不同治疗效果和离散时间生存终点的纵向试验中的最优设计。
Stat Med. 2015 Sep 30;34(22):3060-74. doi: 10.1002/sim.6587. Epub 2015 Jul 14.
9
Interim futility analysis with intermediate endpoints.采用中间终点的期中无效性分析。
Clin Trials. 2008;5(1):14-22. doi: 10.1177/1740774507086648.
10
Sample sizes for time-to-event endpoints: should you insure against chance variations in accrual?生存时间终点的样本量:您是否应该防范入组过程中的偶然变化?
Contemp Clin Trials. 2012 Mar;33(2):456-8. doi: 10.1016/j.cct.2011.10.009. Epub 2011 Nov 9.